Cardiovascular Protective Effects of NP-6A4, a Drug with the FDA Designation for Pediatric Cardiomyopathy, in Female Rats with Obesity and Pre-Diabetes

Background: Obese and pre-diabetic women have a higher risk for cardiovascular death than age-matched men with the same symptoms, and there are no effective treatments. We reported that obese and pre-diabetic female Zucker Diabetic Fatty (ZDF-F) rats recapitulate metabolic and cardiac pathology of y...

Descripción completa

Detalles Bibliográficos
Autores principales: Belenchia, Anthony M., Boukhalfa, Asma, DeMarco, Vincent G., Mehm, Alexander, Mahmood, Abuzar, Liu, Pei, Tang, Yinian, Gavini, Madhavi P., Mooney, Brian, Chen, Howard H., Pulakat, Lakshmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216951/
https://www.ncbi.nlm.nih.gov/pubmed/37408206
http://dx.doi.org/10.3390/cells12101373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216951/
https://www.ncbi.nlm.nih.gov/pubmed/37408206
http://dx.doi.org/10.3390/cells12101373

Ejemplares similares